Xencor, Inc.

XNCRNASDAQ • USD
ThemeHealthcare - Oncology›Immunotherapy & Immuno-Oncology
15.05 USD
↗ 0.31 (2.10%)AT CLOSE (11:59 AM EDT)
15.32
↗ 0.27 (1.77%)
POST MARKET (AS OF 07:55 PM EDT)
Post Market
AS OF 07:55 PM EDT
15.32
↗ 0.27 (1.77%)
🔴Market: CLOSED

Shares of Xencor, Inc. (XNCR) are trading at $15.05. XNCR shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics place XNCR at a fair price relative to peers.

Technical & fundamental data as of Jun 26, 2026.

Open?$14.82
High?$15.57
Low?$14.59
Prev. Close?$14.74
Volume?2.0M
Avg. Volume?828.8K
VWAP?$15.03
Rel. Volume?2.39x
Bid / Ask
Bid?$15.04 × 100
Ask?$16.33 × 600
Spread?$1.29
Midpoint?$15.68
Valuation & Ratios
Market Cap?1.1B
Shares Out?74.1M
Float?74.1M
Float %?100.0%
P/E Ratio?N/A
P/B Ratio?2.16
EPS?-$2.33
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.
Themes
Healthcare - Oncology›Immunotherapy & Immuno-OncologyBiotech - Drug Development›Immunology & Autoimmune
Employees
260
Market Cap
1.1B
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.xencor.com
Listed
2013-12-03
Address
465 N. HALSTEAD ST.
PASADENA, CA 91107
Phone: 626-305-5900
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
13
Momentum?
65
Short Sent.?
39
Piotroski F-Score?2/9Weak
Altman Z-Score?1.12Distress
Confidence?62%Moderate
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?15.18%High
Short Interest?11.3M
Days to Cover?16.2
Free Float74.1M
Avg Daily Volume697.1K
Settlement Date2026-06-15
Financial Health
Current Ratio?6.57Strong
Quick Ratio?6.57Strong
Cash Ratio?0.19Low
Debt/Equity?0.21Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
71
2.16CHEAP▾
P/S?
Peers
100
S&P
6
11.46HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-6.0CHEAP▾
EV/Sales?
Peers
100
S&P
7
12.43HIGH▾
Returns & Efficiency
ROE?
S&P
5
-33.4%WEAK▾
ROA?
S&P
3
-23.4%WEAK▾
Cash Flow & Enterprise
FCF?$-188841000
Enterprise Value?$1.2B
Fundamentals ratios updated end of day
MarketsMoversWatchlist